Pharma & Healthcare
Global Poliovirus Vaccine Market Research Report 2025
- Sep 09, 25
- ID: 497258
- Pages: 83
- Figures: 86
- Views: 6
Report Scope
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine.
The Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine.
The Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Poliovirus Vaccine Market Overview
1.1 Product Definition
1.2 Poliovirus Vaccine by Type
1.2.1 Global Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Poliovirus Vaccine by Application
1.3.1 Global Poliovirus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliovirus Vaccine Revenue 2020-2031
1.4.2 Global Poliovirus Vaccine Sales 2020-2031
1.4.3 Global Poliovirus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
2.8 Global Poliovirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Poliovirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Poliovirus Vaccine Players Market Share by Revenue
2.8.3 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Poliovirus Vaccine Market Scenario by Region
3.1 Global Poliovirus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Poliovirus Vaccine Sales by Region: 2020-2031
3.2.1 Global Poliovirus Vaccine Sales by Region: 2020-2025
3.2.2 Global Poliovirus Vaccine Sales by Region: 2026-2031
3.3 Global Poliovirus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Poliovirus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Poliovirus Vaccine Revenue by Region: 2026-2031
3.4 North America Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Poliovirus Vaccine Sales by Country (2020-2031)
3.4.3 North America Poliovirus Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Poliovirus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Poliovirus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Poliovirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Poliovirus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Poliovirus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Poliovirus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Poliovirus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Poliovirus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Poliovirus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poliovirus Vaccine Sales by Type (2020-2031)
4.1.1 Global Poliovirus Vaccine Sales by Type (2020-2025)
4.1.2 Global Poliovirus Vaccine Sales by Type (2026-2031)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Poliovirus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Poliovirus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Poliovirus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Poliovirus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Poliovirus Vaccine Sales by Application (2020-2031)
5.1.1 Global Poliovirus Vaccine Sales by Application (2020-2025)
5.1.2 Global Poliovirus Vaccine Sales by Application (2026-2031)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Poliovirus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Poliovirus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Poliovirus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Poliovirus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Company Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bibcol Poliovirus Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Company Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Company Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Company Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 IMBCA Poliovirus Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.7.1 Panacea Biotec Ltd Company Information
6.7.2 Panacea Biotec Ltd Description and Business Overview
6.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Company Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Company Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliovirus Vaccine Industry Chain Analysis
7.2 Poliovirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliovirus Vaccine Production Mode & Process Analysis
7.4 Poliovirus Vaccine Sales and Marketing
7.4.1 Poliovirus Vaccine Sales Channels
7.4.2 Poliovirus Vaccine Distributors
7.5 Poliovirus Vaccine Customer Analysis
8 Poliovirus Vaccine Market Dynamics
8.1 Poliovirus Vaccine Industry Trends
8.2 Poliovirus Vaccine Market Drivers
8.3 Poliovirus Vaccine Market Challenges
8.4 Poliovirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Poliovirus Vaccine by Type
1.2.1 Global Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Poliovirus Vaccine by Application
1.3.1 Global Poliovirus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliovirus Vaccine Revenue 2020-2031
1.4.2 Global Poliovirus Vaccine Sales 2020-2031
1.4.3 Global Poliovirus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
2.8 Global Poliovirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Poliovirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Poliovirus Vaccine Players Market Share by Revenue
2.8.3 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Poliovirus Vaccine Market Scenario by Region
3.1 Global Poliovirus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Poliovirus Vaccine Sales by Region: 2020-2031
3.2.1 Global Poliovirus Vaccine Sales by Region: 2020-2025
3.2.2 Global Poliovirus Vaccine Sales by Region: 2026-2031
3.3 Global Poliovirus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Poliovirus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Poliovirus Vaccine Revenue by Region: 2026-2031
3.4 North America Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Poliovirus Vaccine Sales by Country (2020-2031)
3.4.3 North America Poliovirus Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Poliovirus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Poliovirus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliovirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Poliovirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Poliovirus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Poliovirus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Poliovirus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Poliovirus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Poliovirus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Poliovirus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poliovirus Vaccine Sales by Type (2020-2031)
4.1.1 Global Poliovirus Vaccine Sales by Type (2020-2025)
4.1.2 Global Poliovirus Vaccine Sales by Type (2026-2031)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Poliovirus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Poliovirus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Poliovirus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Poliovirus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Poliovirus Vaccine Sales by Application (2020-2031)
5.1.1 Global Poliovirus Vaccine Sales by Application (2020-2025)
5.1.2 Global Poliovirus Vaccine Sales by Application (2026-2031)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Poliovirus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Poliovirus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Poliovirus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Poliovirus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Company Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bibcol Poliovirus Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Company Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Company Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Company Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 IMBCA Poliovirus Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.7.1 Panacea Biotec Ltd Company Information
6.7.2 Panacea Biotec Ltd Description and Business Overview
6.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Company Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Company Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliovirus Vaccine Industry Chain Analysis
7.2 Poliovirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliovirus Vaccine Production Mode & Process Analysis
7.4 Poliovirus Vaccine Sales and Marketing
7.4.1 Poliovirus Vaccine Sales Channels
7.4.2 Poliovirus Vaccine Distributors
7.5 Poliovirus Vaccine Customer Analysis
8 Poliovirus Vaccine Market Dynamics
8.1 Poliovirus Vaccine Industry Trends
8.2 Poliovirus Vaccine Market Drivers
8.3 Poliovirus Vaccine Market Challenges
8.4 Poliovirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Poliovirus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Poliovirus Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Poliovirus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Poliovirus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Poliovirus Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Poliovirus Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Poliovirus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Poliovirus Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Poliovirus Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Poliovirus Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Poliovirus Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Poliovirus Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Poliovirus Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Poliovirus Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Poliovirus Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Poliovirus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Poliovirus Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Poliovirus Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Poliovirus Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Poliovirus Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Poliovirus Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Poliovirus Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Poliovirus Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Poliovirus Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Poliovirus Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Poliovirus Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Poliovirus Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. GSK Poliovirus Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Bibcol Company Information
Table 81. Bibcol Description and Business Overview
Table 82. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bibcol Poliovirus Vaccine Product
Table 84. Bibcol Recent Developments/Updates
Table 85. Serum Institute Company Information
Table 86. Serum Institute Description and Business Overview
Table 87. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Serum Institute Poliovirus Vaccine Product
Table 89. Serum Institute Recent Developments/Updates
Table 90. Tiantan Biological Company Information
Table 91. Tiantan Biological Description and Business Overview
Table 92. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Tiantan Biological Poliovirus Vaccine Product
Table 94. Tiantan Biological Recent Developments/Updates
Table 95. IMBCA Company Information
Table 96. IMBCA Description and Business Overview
Table 97. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. IMBCA Poliovirus Vaccine Product
Table 99. IMBCA Recent Developments/Updates
Table 100. Panacea Biotec Ltd Company Information
Table 101. Panacea Biotec Ltd Description and Business Overview
Table 102. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Panacea Biotec Ltd Poliovirus Vaccine Product
Table 104. Panacea Biotec Ltd Recent Developments/Updates
Table 105. Bio-Med Company Information
Table 106. Bio-Med Description and Business Overview
Table 107. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Med Poliovirus Vaccine Product
Table 109. Bio-Med Recent Developments/Updates
Table 110. Halfkin Bio-Pharmaceuticals Company Information
Table 111. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 112. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product
Table 114. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Poliovirus Vaccine Distributors List
Table 118. Poliovirus Vaccine Customers List
Table 119. Poliovirus Vaccine Market Trends
Table 120. Poliovirus Vaccine Market Drivers
Table 121. Poliovirus Vaccine Market Challenges
Table 122. Poliovirus Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Poliovirus Vaccine
Figure 2. Global Poliovirus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Poliovirus Vaccine Market Share by Type: 2024 & 2031
Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
Figure 5. Oral Polio Vaccine (OPV) Product Picture
Figure 6. Global Poliovirus Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Poliovirus Vaccine Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Poliovirus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Poliovirus Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Poliovirus Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global Poliovirus Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. Poliovirus Vaccine Report Years Considered
Figure 15. Poliovirus Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Poliovirus Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Poliovirus Vaccine Players: Market Share by Revenue in Poliovirus Vaccine in 2024
Figure 18. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. the United States Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Poliovirus Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Poliovirus Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Poliovirus Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Poliovirus Vaccine by Type (2020-2031)
Figure 54. Global Poliovirus Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Poliovirus Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Poliovirus Vaccine by Application (2020-2031)
Figure 57. Global Poliovirus Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. Poliovirus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Poliovirus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Poliovirus Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Poliovirus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Poliovirus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Poliovirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Poliovirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Poliovirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Poliovirus Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Poliovirus Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Poliovirus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Poliovirus Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Poliovirus Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Poliovirus Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Poliovirus Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Poliovirus Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Poliovirus Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Poliovirus Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Poliovirus Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Poliovirus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Poliovirus Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Poliovirus Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Poliovirus Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Poliovirus Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Poliovirus Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Poliovirus Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Poliovirus Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Poliovirus Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Poliovirus Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Poliovirus Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Poliovirus Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. GSK Poliovirus Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Bibcol Company Information
Table 81. Bibcol Description and Business Overview
Table 82. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bibcol Poliovirus Vaccine Product
Table 84. Bibcol Recent Developments/Updates
Table 85. Serum Institute Company Information
Table 86. Serum Institute Description and Business Overview
Table 87. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Serum Institute Poliovirus Vaccine Product
Table 89. Serum Institute Recent Developments/Updates
Table 90. Tiantan Biological Company Information
Table 91. Tiantan Biological Description and Business Overview
Table 92. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Tiantan Biological Poliovirus Vaccine Product
Table 94. Tiantan Biological Recent Developments/Updates
Table 95. IMBCA Company Information
Table 96. IMBCA Description and Business Overview
Table 97. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. IMBCA Poliovirus Vaccine Product
Table 99. IMBCA Recent Developments/Updates
Table 100. Panacea Biotec Ltd Company Information
Table 101. Panacea Biotec Ltd Description and Business Overview
Table 102. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Panacea Biotec Ltd Poliovirus Vaccine Product
Table 104. Panacea Biotec Ltd Recent Developments/Updates
Table 105. Bio-Med Company Information
Table 106. Bio-Med Description and Business Overview
Table 107. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Med Poliovirus Vaccine Product
Table 109. Bio-Med Recent Developments/Updates
Table 110. Halfkin Bio-Pharmaceuticals Company Information
Table 111. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 112. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product
Table 114. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Poliovirus Vaccine Distributors List
Table 118. Poliovirus Vaccine Customers List
Table 119. Poliovirus Vaccine Market Trends
Table 120. Poliovirus Vaccine Market Drivers
Table 121. Poliovirus Vaccine Market Challenges
Table 122. Poliovirus Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Poliovirus Vaccine
Figure 2. Global Poliovirus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Poliovirus Vaccine Market Share by Type: 2024 & 2031
Figure 4. Inactivated Polio Vaccine (IPV) Product Picture
Figure 5. Oral Polio Vaccine (OPV) Product Picture
Figure 6. Global Poliovirus Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Poliovirus Vaccine Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Poliovirus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Poliovirus Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Poliovirus Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global Poliovirus Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. Poliovirus Vaccine Report Years Considered
Figure 15. Poliovirus Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Poliovirus Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Poliovirus Vaccine Players: Market Share by Revenue in Poliovirus Vaccine in 2024
Figure 18. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. the United States Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Poliovirus Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Poliovirus Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Poliovirus Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Poliovirus Vaccine by Type (2020-2031)
Figure 54. Global Poliovirus Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Poliovirus Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Poliovirus Vaccine by Application (2020-2031)
Figure 57. Global Poliovirus Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. Poliovirus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232